Literature DB >> 29475817

Mini-Review: What Is New in Urolift?

Giuseppe Magistro1, Christian G Stief2, Henry H Woo3.   

Abstract

CONTEXT: Lower urinary tract symptoms (LUTS) are one of the most common benign conditions affecting aging men. Among surgical procedures, minimally invasive treatment options have emerged with the main objective to be at least equally effective as current standard techniques, but with a more favourable safety profile.
OBJECTIVE: To present the technical principle for prostatic urethral lift (PUL) and review clinical outcomes. EVIDENCE ACQUISITION: Medline, PubMed, the Cochrane database, and Embase were screened for randomised controlled trials, clinical trials, and reviews on PUL. EVIDENCE SYNTHESIS: Data from the L.I.F.T study proved that PUL can provide rapid and durable relief of LUTS without compromising sexual function. The BPH6 trial compared PUL with transurethral resection of the prostate (TURP), and its outcomes indicated that improvement of LUTS was more pronounced after TURP, whereas PUL was superior in terms of quality of recovery, ejaculatory function, and quality of sleep.
CONCLUSIONS: PUL is an attractive option for selected patients who seek rapid and durable relief of LUTS with complete preservation of sexual function and fast recovery after intervention. PATIENT
SUMMARY: Prostatic urethral lift is an efficient and safe minimally invasive procedure that offers rapid and durable relief of lower urinary tract symptoms without compromising sexual function.
Copyright © 2018 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Benign prostatic hyperplasia; Lower urinary tract symptoms; Minimally invasive treatment; Prostatic urethral lift

Mesh:

Year:  2018        PMID: 29475817     DOI: 10.1016/j.euf.2018.01.013

Source DB:  PubMed          Journal:  Eur Urol Focus        ISSN: 2405-4569


  5 in total

1.  Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Jae Hung Jung; Balaji Reddy; Karen Ann McCutcheon; Michael Borofsky; Vikram Narayan; Myung Ha Kim; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2019-05-25

Review 2.  Meta-analysis and systematic review of intermediate-term follow-up of prostatic urethral lift for benign prostatic hyperplasia.

Authors:  Karthik Tanneru; Shiva Gautam; Daniel Norez; Jatinder Kumar; Muhammad Umar Alam; Shahriar Koocheckpour; K C Balaji; Costa Joseph
Journal:  Int Urol Nephrol       Date:  2020-02-17       Impact factor: 2.370

Review 3.  Minimally Invasive Therapies for Benign Prostatic Obstruction: A Review of Currently Available Techniques Including Prostatic Artery Embolization, Water Vapor Thermal Therapy, Prostatic Urethral Lift, Temporary Implantable Nitinol Device and Aquablation.

Authors:  Tiago Bilhim; Patrick Betschart; Pavel Lyatoshinsky; Gautier Müllhaupt; Dominik Abt
Journal:  Cardiovasc Intervent Radiol       Date:  2022-01-18       Impact factor: 2.740

4.  Real-world data comparing minimally invasive surgeries for benign prostatic hyperplasia.

Authors:  Brendan L Raizenne; Xinyan Zheng; Jialin Mao; Kevin C Zorn; Ahra Cho; Dean Elterman; Naeem Bhojani; Art Sedrakyan; Bilal Chughtai
Journal:  World J Urol       Date:  2022-02-02       Impact factor: 4.226

Review 5.  An Update on the Outcomes of Patients Treated with Urolift for Benign Prostatic Hyperplasia.

Authors:  Justin Loloi; Nathan Feiertag; Kripali Gautam; Pedro Maria
Journal:  Res Rep Urol       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.